JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 20, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/30/27753    most recent
C100221200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, M. J.
Right arrow Articles by Chandy, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M. J.
Right arrow Articles by Chandy, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print June 6, 2001
J. Biol. Chem, 10.1074/jbc.C100221200
Submitted on May 1, 2001
Revised on June 6, 2001
Accepted on June 6, 2001

Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia

Mark J. Miller, Heiko Rauer, Hiroaki Tomita, Heike Rauer, J. Jay Gargus, George A. Gutman, Michael D. Cahalan, and K. George Chandy

Department of Physiology and Biophysics, University of California Irvine, Irvine, CA 92697

Corresponding Author: gchandy{at}uci.edu

The small-conductance calcium-activated K+ channel gene SKCa3 / KCNN3 maps to 1q21, a region strongly linked to schizophrenia. Recently, a 4 bp deletion in SKCa3 was reported in a patient with schizophrenia. This frame-shift mutation would truncate the protein at the end of the N-terminal cytoplasmic region (SKCa3). We generated a GFP-SKCa3 N-terminal construct (SKCa3-1/285) that is identical to SKCa3 except for the last two residues. Using confocal microscopy we demonstrate that SKCa3-1/285 localizes rapidly and exclusively to the nucleus of mammalian cells like several other pathogenic polyglutamine containing proteins. This nuclear targeting is mediated in part by two polybasic sequences present at the C-terminal end of SKCa3-1/285. In contrast, full-length SKCa3, SKCa2 and IKCa1 polypeptides are all excluded from the nucleus and express as functional channels. When over-expressed in human Jurkat T cells, SKCa3-1/285 can suppress endogenous SKCa2 currents, but not voltage-gated K+ currents. This dominant negative suppression is most likely mediated through the co-assembly of SKCa3-1/285 with native subunits and the formation of non-functional tetramers. The nuclear localization of SKCa3-1/285 may alter neuronal architecture, and its ability to dominantly suppress endogenous SKCa currents may affect patterns of neuronal firing. Together, these two effects may play a part in the pathogenesis of schizophrenia and other neuropsychiatric disorders.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
P. A. Ferreira
Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms
Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R259 - R267.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
X. Lu, M. Guruju, J. Oswald, and P. A. Ferreira
Limited proteolysis differentially modulates the stability and subcellular localization of domains of RPGRIP1 that are distinctly affected by mutations in Leber's congenital amaurosis
Hum. Mol. Genet., May 15, 2005; 14(10): 1327 - 1340.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Vijai, A Kapoor, H M Ravishankar, P J Cherian, G Kuruttukulam, B Rajendran, R Sridharan, G Rangan, A S Girija, S Jayalakshmi, et al.
Protective and susceptibility effects of hSKCa3 allelic variants on juvenile myoclonic epilepsy
J. Med. Genet., May 1, 2005; 42(5): 439 - 442.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kolski-Andreaco, H. Tomita, V. G. Shakkottai, G. A. Gutman, M. D. Cahalan, J. J. Gargus, and K. G. Chandy
SK3-1C, a Dominant-negative Suppressor of SKCa and IKCa Channels
J. Biol. Chem., February 20, 2004; 279(8): 6893 - 6904.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Monaghan, D. C. H. Benton, P. K. Bahia, R. Hosseini, Y. A. Shah, D. G. Haylett, and G. W. J. Moss
The SK3 Subunit of Small Conductance Ca2+-activated K+ Channels Interacts with Both SK1 and SK2 Subunits in a Heterologous Expression System
J. Biol. Chem., January 9, 2004; 279(2): 1003 - 1009.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. D. Rhodes, D. J. Collison, and G. Duncan
Calcium Activates SK Channels in the Intact Human Lens
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3927 - 3932.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Lhuillier and S. E. Dryer
Developmental Regulation of Neuronal KCa Channels by TGFbeta 1: An Essential Role for PI3 Kinase Signaling and Membrane Insertion
J Neurophysiol, August 1, 2002; 88(2): 954 - 964.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.